James R. Murphy

R.J. Reynolds Tobacco Holdings, Inc. manufactures and markets cigarettes and tobacco products. The company was founded in 1970 and is headquartered in Winston-Salem, NC.

Tutogen Medical, Inc. manufactures sterile biological implant products made from human and animal tissue. Tutogen utilizes its Tutoplast Process® of tissue preservation and viral inactivation to manufacture and deliver sterile bio-implants used in spinal/trauma, urology, dental, ophthalmology and general surgery procedures. The Company''s Tutoplast® products are sold and distributed worldwide by Zimmer Spine and Zimmer Dental, subsidiaries of Zimmer Holdings, Inc. the Mentor Corporation, IOP, Inc. and through independent distributors and subsidiaries in the U.S. and other international markets. Tutogen Medical is located in West Paterson, NJ.

Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ.

Biologics, Inc. provides oncology care services. Its services include care integration, oncology pharmacy services, patient access, strategic market solutions, and clinical research services. The company was founded in 1994 and is headquartered in Cary, NC.

Part of Boston Scientific Corp., BTG International Ltd. is a British company that engages in research and experimental development on natural sciences and engineering. The company is based in London, UK and was founded in 1991.

Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY.

MedPointe, Inc. develops, markets, and sells therapeutics. The company's products include respiratory, allergy, central nervous system, cough/cold, and pediatric products. The company was founded by James S. Burns and Anthony H. Wild in 2001 and is headquartered in Somerset, NJ.

Velico Medical, Inc. operates as a pre-clinical medical technology company that develops and commercializes products for use in preparing and storing platelets and plasma, including a companion instrument and disposable product for spray drying plasma. Its products include FrontlineODP (on demand Plasma) and FrontlinePPS (Platelet Protection System). The company was founded by Robert W. Middleton and Cabot G. L. Henderson in 1991 and is headquartered in Beverly, MA.

VERION AG operates as an investment holding company, which engages in the acquisition, management, and sale of shareholdings in companies. It also engages in other activities related to its business operations. The company was founded in 2005 and is headquartered in Munich, Germany

CommGeniX LLC operates as a medical communications agency. It combines unrivaled therapeutic expertise with program design and delivery. The firm offers content development, speaker bureau management, strategic business communications, thought leader development and program management and logistics. The company was founded by Jody Simon in 2000 and is headquartered in Tampa, FL.

Hawthorn Pharmaceuticals, Inc. develops, markets, and sells pharmaceutical products. The company is headquartered in Madison, MS.

Pernix Therapeutics LLC is engaged in the development, marketing, and sale of generic pharmaceutical products. The company was founded on October 2, 2009 and is headquartered in Gonzales, LA.

Emerald Health Pharmaceuticals, Inc. engages in the development of medicines based on cannabinoid science. It focuses on discovering, developing, and commercializing proprietary cannabinoid-derived medicines. The company is headquartered in San Diego, CA.

Induce Biologics, Inc. is a medicine company. The firm is develops bio implants for bone regeneration. It also offers URIST product. The company was founded by Sean Peel and is headquartered in Toronto, Canada.

Sedor Pharmaceuticals LLC is a pharmaceutical company that identifies, acquires, and develops acute care pharmaceutical assets for commercial licensing. The private company is based in Paoli, PA, and was founded by John A. Sedor and Barry R. Frankel. The company's lead product, Sesquient, has received FDA approval for the treatment of status epilepticus, and they are preparing to enter phase I development of their second product, Meloxicam for injection solubilized with betadex sulfobutyl ether sodium, for the potential treatment of acute post-surgical pain. Both products were licensed from Ligand Pharmaceuticals. The company is led by Chairman and CEO John Sedor and an experienced team of pharmaceutical professionals. John A. Sedor has been the CEO since incorporation.